KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sabra Health Care REIT (SBRA) Short-Term Debt issuances (2016 - 2025)

Sabra Health Care REIT (SBRA) has 10 years of Short-Term Debt issuances data on record, last reported at -$65.0 million in Q4 2025.

  • For Q4 2025, Short-Term Debt issuances fell 46.99% year-over-year to -$65.0 million; the TTM value through Dec 2025 reached $109.8 million, up 652.35%, while the annual FY2025 figure was $109.8 million, 652.35% up from the prior year.
  • Short-Term Debt issuances reached -$65.0 million in Q4 2025 per SBRA's latest filing, down from $119.7 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $125.8 million in Q2 2022 and bottomed at -$118.4 million in Q1 2023.
  • Average Short-Term Debt issuances over 4 years is $14.0 million, with a median of $18.1 million recorded in 2022.
  • Peak YoY movement for Short-Term Debt issuances: tumbled 1429.62% in 2023, then skyrocketed 610.99% in 2025.
  • A 4-year view of Short-Term Debt issuances shows it stood at $56.7 million in 2022, then grew by 7.6% to $61.0 million in 2023, then crashed by 172.49% to -$44.2 million in 2024, then plummeted by 46.99% to -$65.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Short-Term Debt issuances were -$65.0 million in Q4 2025, $119.7 million in Q3 2025, and $79.0 million in Q2 2025.